Cabazitaxel

Drug Index

Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid.[2] It is a microtubule inhibitor,[1] and the fourth taxane to be approved as a cancer therapy.[citation needed] Cabazitaxel was developed by Sanofi-Aventis and was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer in June 2010.[3][4][5] It...

What is the hcpc's code for Cabazitaxel? ## I am afraid you're going to have to be little more specific. I did try a search, but such abbreviations are not universal. I did try a search, but brought up several health care organizations, so I need to know which one you are talking about. Can you please post back?

1 REPLY

Cabazitaxel

Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid.[2] It is a microtubule inhibitor,[1] and the fourth taxane to be approved as a cancer therapy.[citation needed] Cabazitaxel was developed by Sanofi-Aventis and was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer in June 2010.[3][4][5] It...

NDC Database

Jevtana Kit by Sanofi-aventis U.S. LLC ## Package Codes: 0024-5824-11 ## Active Ingredients: Cabazitaxel